Boston Biomedical is defunct.

Renamed Sumitomo Dainippon Pharma Oncology, Jun 2020; Bought by Dainippon Sumitomo Pharma, Feb 2012, $200M plus milestones up to $2.4B


------------------
If you believe any of this information is incorrect, please let us know.